glp 1 agonist treatment GLP-1 Medications: Everything You Need to Know Metabolic Flux Adaptations During GLP-1
Description
Conclusion The rising off-label use of GLP1 RAs presents new challenges for esthetic medicine
Still have a question
J Clin Endocrinol Metab 100(6):22482253
If additional glycemic control is needed, the dose can be increased in 2.5-mg increments every 4 weeks to a maximum of 15 mg once weekly
This process delays treatment by 37 days on average and sometimes results in denial if the plan's criteria are not met
doi: 10.1016/j.cmet.2018.03.001 [DOI] [PubMed] [Google Scholar] 97
